4±6
This meta-analysis integrated randomized controlled trials (RCTs) in which mosapride
Combination therapy with pantoprazole and mosapride was more effective than pantoprazole alone in providing symptomatic
See et al
Medically reviewed by
Omeprazole, lansoprazole and pantoprazole are mainly catabolized and inactivated by the liver enzyme, CYP2C19
We
Compare prices for generic mosapride/pantoprazole substitutes: Moza Plus, MOZA-PLUS, PANTEC PLUS
2009 to Dec
Comparison of efficacy of pantoprazole alone versus pantoprazole plus mosapride in therapy of gastroesophageal reflux disease: a randomized trial
Introduction The treatment of gastroesophageal reflux disease (GERD) mainly involves the use of potent acid suppressive therapy both for the healing of esophagitis and the
Of the total drug interactions, 21 are major, 143 are moderate, and 34 are minor
1599 μg/mL and 0
Pulmonary func-tion parameters and sleep quality indexes before and after treatment were compared
1790μg/mL respectively, while LOQ for these were respectively 0
LBG In the baseline population of individuals who are not pregnant, gastroesophageal reflux disease (GERD) is present in approximately 40% of Americans on a monthly basis and approximately 7–10% of Americans on a daily or weekly basis
In a recent meta-analysis, mosapride combined with PPI significantly improved the reflux-symptom score compared to PPI alone, specifically in patients with ERD [ 18 ]
Madan et al demonstrated that the combination therapy with pantoprazole and mosapride was more effective than pantoprazole alone in providing symptomatic relief to patients with erosive GERD